ERYTHROMYCIN ETHYLSUCCINATE (ERYTHROMYCIN ETHYLSUCCINATE) — FDA Approval ANDA062847 (AUROBINDO PHARMA USA)
ERYTHROMYCIN ETHYLSUCCINATE (ERYTHROMYCIN ETHYLSUCCINATE) — FDA Approval ANDA062847 (AUROBINDO PHARMA USA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ERYTHROMYCIN ETHYLSUCCINATE; Active ingredients: ERYTHROMYCIN ETHYLSUCCINATE; Application number: ANDA062847.
| Brand name | ERYTHROMYCIN ETHYLSUCCINATE |
|---|---|
| Active ingredients | ERYTHROMYCIN ETHYLSUCCINATE |
| Application number | ANDA062847 |
| Sponsor | AUROBINDO PHARMA USA |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19880914 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →